Literature DB >> 17523004

Storage conditions for stability testing of pharmaceuticals in hot and humid regions.

Rubiana F Bott1, Wanderley P Oliveira.   

Abstract

A review of the methodology for determination of the storage conditions for stability testing according to Schumacher/Grimm is presented in this paper. The purpose is to provide scientific information useful for the definition of storage conditions for stability testing of pharmaceuticals suitable to the region where the product will be dispensed. Special attention is given to stability testing in the new markets located in developing countries with very hot and humid climates. Finally, storage conditions for stability testing in the Brazilian regions were derived and examined comparatively with the guidelines of the world health organization (WHO) and regulatory bodies. The storage conditions were derived from the calculated values of the mean kinetic temperature and the relative humidity (RH). These parameters were estimated from daily values of dry and dew point temperatures of all Brazilian capitals from 1998 to 2002; collected in the morning (9 a.m.), in the afternoon (3 p.m.), and at night (9 p.m.). The Brazilian Center of Weather Forecast and Climatic Studies of the National Institute of Spatial Research (CPTEC/INPE) kindly furnished these data. Significant differences of the mean kinetic temperature (MKT) and relative humidity (RH) for Brazilian regions were observed. These results indicate the existence of a high climatic diversity between the Brazilian regions, making challenging the definition of a single storage condition for the stability testing. Some regions present RH values higher than 80%, giving support to the concerns of the WHO, indicating the necessity of revision of existing guidelines for stability testing mainly for very hot and humid regions.

Mesh:

Substances:

Year:  2007        PMID: 17523004     DOI: 10.1080/03639040600975022

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  9 in total

1.  Design of an active ultrastable single-chain insulin analog: synthesis, structure, and therapeutic implications.

Authors:  Qing-xin Hua; Satoe H Nakagawa; Wenhua Jia; Kun Huang; Nelson B Phillips; Shi-quan Hu; Michael A Weiss
Journal:  J Biol Chem       Date:  2008-03-10       Impact factor: 5.157

2.  Metal-Organic Framework Encapsulation Preserves the Bioactivity of Protein Therapeutics.

Authors:  Congzhou Wang; Gail Sudlow; Zheyu Wang; Sisi Cao; Qisheng Jiang; Alicia Neiner; Jeremiah J Morrissey; Evan D Kharasch; Samuel Achilefu; Srikanth Singamaneni
Journal:  Adv Healthc Mater       Date:  2018-10-19       Impact factor: 9.933

3.  Aligning new interventions with developing country health systems: target product profiles, presentation, and clinical trial design.

Authors:  Alan Brooks; Julia K Nunes; Andrew Garnett; Robin Biellik; Didier Leboulleux; Ashley J Birkett; Christian Loucq
Journal:  Glob Public Health       Date:  2012-07-11

Review 4.  Stability of chronic medicines in dosage administration aids. How much have been done?

Authors:  Joyce Zhen Yin Tan; Yu Heng Kwan
Journal:  Saudi Pharm J       Date:  2014-02-25       Impact factor: 4.330

5.  Rapid Recovery of Clofazimine-Loaded Nanoparticles with Long-Term Storage Stability as Anti-Cryptosporidium Therapy.

Authors:  Jie Feng; Yingyue Zhang; Simon A McManus; Kurt D Ristroph; Hoang D Lu; Kai Gong; Claire E White; Robert K Prud'homme
Journal:  ACS Appl Nano Mater       Date:  2018-04-20

6.  Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale.

Authors:  Jie Feng; Chester E Markwalter; Chang Tian; Madeleine Armstrong; Robert K Prud'homme
Journal:  J Transl Med       Date:  2019-06-14       Impact factor: 5.531

7.  The Effect of Polymers on Drug Release Kinetics in Nanoemulsion In Situ Gel Formulation.

Authors:  K Reeta Vijaya Rani; Sruthi Rajan; Mullaicharam Bhupathyraaj; R Krishna Priya; Nirmala Halligudi; Mohammad Abobakr Al-Ghazali; Sathvik B Sridhar; Javedh Shareef; Sabin Thomas; Saleem M Desai; Pandurang D Pol
Journal:  Polymers (Basel)       Date:  2022-01-21       Impact factor: 4.329

8.  Long-Term Stability Prediction for Developability Assessment of Biopharmaceutics Using Advanced Kinetic Modeling.

Authors:  Andreas Evers; Didier Clénet; Stefania Pfeiffer-Marek
Journal:  Pharmaceutics       Date:  2022-02-08       Impact factor: 6.321

9.  Exploration of ethyl anthranilate-loaded monolithic matrix-type prophylactic polymeric patch.

Authors:  Johirul Islam; Kamaruz Zaman; Srijita Chakrabarti; Nilutpal Sharma Bora; Manash Pratim Pathak; Santa Mandal; Julfikar Ali Junejo; Pronobesh Chattopadhyay
Journal:  J Food Drug Anal       Date:  2016-12-05       Impact factor: 6.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.